Iressa 2nd Line Phase III Study in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients
- Status
- SUSPENDED
- Phase
- PHASE3
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
OSI-774 (Erlotinib, Tarceva) in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Follow-up of Patients With Curative-intent Surgical Resection for NSCLC
- Status
- COMPLETED
- Phase
- NA
A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.
- Status
- COMPLETED
- Phase
- N/A